Penumbra General and Administrative Expenses 2011-2026 | PEN

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Penumbra

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
574 M	506 M	450 M	378 M	287 M	273 M	226 M	184 M	148 M	102 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
574 M	102 M	313 M

Quarterly General and Administrative Expenses Penumbra

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
169 M	160 M	153 M	140 M	142 M	144 M	126 M	127 M	123 M	-	109 M	115 M	111 M	-	94.4 M	90.6 M	79.8 M	-	76.2 M	59.9 M	74.5 M	-	69.3 M	67.7 M	61.1 M	-	55.9 M	54.8 M	54.5 M	-	46 M	44.2 M	42.7 M	-	37.7 M	35.9 M	33.1 M	-	26.8 M	26.4 M	19.5 M	-	16.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
169 M	16.6 M	81.9 M

General and Administrative Expenses of other stocks in the Medical devices industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
AxoGen AXGN	39 M	$ 33.22	1.87 %	$ 1.47 B	USA
Allied Healthcare Products AHPI	7.11 M	-	3.58 %	$ 2.21 M	USA
Apollo Endosurgery APEN	20.6 M	-	-	$ 475 M	USA
GenMark Diagnostics, Inc. GNMK	25.6 M	-	-	$ 1.77 B	USA
Axonics Modulation Technologies AXNX	40.2 M	-	-	$ 3.31 B	USA
Acutus Medical AFIB	14.1 M	-	-26.83 %	$ 2.62 M	USA
Obalon Therapeutics, Inc. OBLN	8.78 M	-	-5.86 %	$ 30.6 M	USA
Aziyo Biologics AZYO	14.1 M	-	1.37 %	$ 20.5 M	USA
Cognyte Software Ltd. CGNT	163 M	$ 7.01	2.04 %	$ 503 M	Israel
Apyx Medical Corporation APYX	22.2 M	$ 3.76	-1.7 %	$ 130 M	USA
Alphatec Holdings ATEC	450 M	$ 13.29	1.41 %	$ 1.9 B	USA
BIOLASE BIOL	10.2 M	-	-13.19 %	$ 166 K	USA
Bio-Rad Laboratories BIO	814 M	$ 255.19	-12.51 %	$ 7.2 B	USA
Conformis CFMS	28.8 M	-	-	$ 16.4 M	USA
Bruker Corporation BRKR	894 M	$ 36.35	-3.09 %	$ 5.42 K	USA
BioSig Technologies BSGM	11.6 M	-	37.08 %	$ 85.7 M	USA
CONMED Corporation CNMD	117 M	$ 41.59	-0.28 %	$ 1.28 B	USA
Boston Scientific Corporation BSX	5.98 B	$ 74.77	0.88 %	$ 110 B	USA
Abbott Laboratories ABT	11.7 B	$ 112.22	0.66 %	$ 195 B	USA
Cardiovascular Systems CSII	171 M	-	0.15 %	$ 844 M	USA
EDAP TMS S.A. EDAP	5.9 M	$ 4.8	0.63 %	$ 179 M	France
Delcath Systems DCTH	29.6 M	$ 9.25	1.43 %	$ 264 M	USA
Cutera CUTR	63.3 M	-	-10.19 %	$ 1.99 M	USA
CryoLife, Inc. CRY	141 M	-	-4.14 %	$ 702 M	USA
ClearPoint Neuro CLPT	12 M	$ 13.44	3.07 %	$ 363 M	USA
Electromed ELMD	39.3 M	$ 24.2	3.82 %	$ 205 M	USA
Soliton, Inc. SOLY	8.46 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	4.88 K	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	8.5 M	-	0.03 %	$ 1.58 B	Israel
Dynatronics Corporation DYNT	8.46 M	-	14.99 %	$ 929 K	USA
Misonix, Inc. MSON	18 M	-	-	$ 462 M	USA
Neovasc NVCN	14.7 M	-	-	$ 111 M	Canada
Intersect ENT, Inc. XENT	98.6 M	-	-	$ 955 M	USA
Eargo EAR	54.3 M	-	-	$ 10.2 M	USA
Inogen INGN	72.6 M	$ 5.71	-1.38 %	$ 135 M	USA
InMode Ltd. INMD	8.41 M	$ 14.36	0.38 %	$ 1.14 B	Israel
IRadimed Corporation IRMD	15.9 M	$ 99.81	-0.03 %	$ 1.26 B	USA
GBS GBS	8.88 M	-	-0.57 %	$ 7.12 M	USA
Integer Holdings Corporation ITGR	185 M	$ 85.46	0.23 %	$ 2.87 B	USA
Second Sight Medical Products EYES	806 K	-	-0.97 %	$ 54.4 M	USA
Avinger AVGR	14.1 M	-	-20.74 %	$ 369 K	USA
FONAR Corporation FONR	23.5 M	$ 18.55	0.05 %	$ 122 M	USA
Pulmonx Corporation LUNG	102 M	$ 1.47	3.17 %	$ 57.5 M	USA
Globus Medical GMED	981 M	$ 87.89	0.76 %	$ 11.9 B	USA
Integra LifeSciences Holdings Corporation IART	717 M	$ 11.29	4.46 %	$ 869 M	USA
Myomo MYO	18.4 M	$ 0.82	0.41 %	$ 5.78 M	USA
Establishment Labs Holdings ESTA	140 M	$ 75.22	2.28 %	$ 2.12 B	Costa-rica